EA200970616A1 - Соединения имидазолидинониламинопиримидина - Google Patents

Соединения имидазолидинониламинопиримидина

Info

Publication number
EA200970616A1
EA200970616A1 EA200970616A EA200970616A EA200970616A1 EA 200970616 A1 EA200970616 A1 EA 200970616A1 EA 200970616 A EA200970616 A EA 200970616A EA 200970616 A EA200970616 A EA 200970616A EA 200970616 A1 EA200970616 A1 EA 200970616A1
Authority
EA
Eurasian Patent Office
Prior art keywords
aminomethyl
hydrogen
halo
alkyl
ethyl
Prior art date
Application number
EA200970616A
Other languages
English (en)
Other versions
EA016178B1 (ru
Inventor
Хун-Юй Ли
Харольд Бернс Брукс
Джойс З. Крич
Джеймс Роберт Генри
Джейсон Скотт Сойер
Ян Ванг
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of EA200970616A1 publication Critical patent/EA200970616A1/ru
Publication of EA016178B1 publication Critical patent/EA016178B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

Настоящее изобретение относится к новым соединениям имидазолидинониламинопиримидина, которые могут иметь клиническое применение при лечении рака путем ингибирования Plk1.
EA200970616A 2006-12-21 2007-12-11 Соединения имидазолидинониламинопиримидина EA016178B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87132206P 2006-12-21 2006-12-21
PCT/US2007/087046 WO2008076705A1 (en) 2006-12-21 2007-12-11 Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer

Publications (2)

Publication Number Publication Date
EA200970616A1 true EA200970616A1 (ru) 2009-10-30
EA016178B1 EA016178B1 (ru) 2012-02-28

Family

ID=39185681

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200970616A EA016178B1 (ru) 2006-12-21 2007-12-11 Соединения имидазолидинониламинопиримидина

Country Status (21)

Country Link
US (1) US8063212B2 (ru)
EP (1) EP2125794B1 (ru)
JP (1) JP2010513553A (ru)
KR (1) KR101080594B1 (ru)
CN (1) CN101568539B (ru)
AT (1) ATE485291T1 (ru)
AU (1) AU2007334040B2 (ru)
BR (1) BRPI0720607A2 (ru)
CA (1) CA2673564A1 (ru)
CY (1) CY1110950T1 (ru)
DE (1) DE602007010041D1 (ru)
DK (1) DK2125794T3 (ru)
EA (1) EA016178B1 (ru)
ES (1) ES2351371T3 (ru)
HR (1) HRP20100641T1 (ru)
MX (1) MX2009006635A (ru)
PL (1) PL2125794T3 (ru)
PT (1) PT2125794E (ru)
RS (1) RS51526B (ru)
SI (1) SI2125794T1 (ru)
WO (1) WO2008076705A1 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101563342B (zh) 2006-12-21 2012-09-05 伊莱利利公司 用于治疗癌症的咪唑啉酮基氨基嘧啶化合物
TW200908981A (en) * 2007-05-16 2009-03-01 Lilly Co Eli Triazolyl aminopyrimidine compounds
EP2862861B1 (en) 2012-06-14 2016-01-06 Daiichi Sankyo Company, Limited Piperidinylpyrazolopyridine derivative
EP2929883A1 (en) 2014-04-08 2015-10-14 Institut Pasteur Pyrazole derivatives as dihydroorotate dehydrogenase (DHODH) inhibitors
KR20230142927A (ko) 2022-04-04 2023-10-11 경희대학교 산학협력단 나프탈렌-2-일알킬기가 치환된 이미다졸리움 유도체 및 이를 유효성분으로 포함하는 암 치료용 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929726A (en) 1988-02-09 1990-05-29 Georgia State University Foundation, Inc. Novel diazines and their method of preparation
WO2004063192A1 (en) 2003-01-10 2004-07-29 Pharmacopeia Drug Discovery, Inc. Imidazolyl pyrimidine derivatives useful as il-8 receptor modulators
GB0308466D0 (en) 2003-04-11 2003-05-21 Novartis Ag Organic compounds
EP1831207B1 (en) 2004-12-17 2012-11-14 Amgen Inc. Aminopyrimidine compounds as plk inhibitors
TW200800201A (en) * 2005-11-18 2008-01-01 Lilly Co Eli Pyrimidinyl benzothiophene compounds
CN101437519A (zh) 2006-03-31 2009-05-20 艾博特公司 吲唑化合物
CN101563342B (zh) 2006-12-21 2012-09-05 伊莱利利公司 用于治疗癌症的咪唑啉酮基氨基嘧啶化合物
JP5204838B2 (ja) 2007-05-16 2013-06-05 イーライ リリー アンド カンパニー トリアゾリルアミノピリミジン化合物
TW200908981A (en) 2007-05-16 2009-03-01 Lilly Co Eli Triazolyl aminopyrimidine compounds

Also Published As

Publication number Publication date
CN101568539B (zh) 2012-04-25
KR20090086111A (ko) 2009-08-10
PT2125794E (pt) 2011-01-10
EP2125794B1 (en) 2010-10-20
ES2351371T3 (es) 2011-02-03
HRP20100641T1 (hr) 2010-12-31
AU2007334040B2 (en) 2012-02-16
RS51526B (en) 2011-06-30
BRPI0720607A2 (pt) 2014-04-08
DK2125794T3 (da) 2011-01-24
SI2125794T1 (sl) 2011-02-28
MX2009006635A (es) 2009-06-30
KR101080594B1 (ko) 2011-11-04
JP2010513553A (ja) 2010-04-30
CY1110950T1 (el) 2015-06-10
PL2125794T3 (pl) 2011-04-29
AU2007334040A1 (en) 2008-06-26
US20100081641A1 (en) 2010-04-01
CA2673564A1 (en) 2008-06-26
WO2008076705A1 (en) 2008-06-26
EP2125794A1 (en) 2009-12-02
US8063212B2 (en) 2011-11-22
CN101568539A (zh) 2009-10-28
DE602007010041D1 (de) 2010-12-02
EA016178B1 (ru) 2012-02-28
ATE485291T1 (de) 2010-11-15

Similar Documents

Publication Publication Date Title
TW200642683A (en) Heterocyclic compound
TW200621786A (en) Condensed pyrazole derivatives, their preparation and application in therapeutics
WO2005080384A3 (en) Benzimidazole derivative and use as aii receptor antagonist
SI2091948T1 (sl) Novi inhibitorji glutaminil ciklaze
EA200501585A1 (ru) Производные азетидинкарбоксамида и их применение при лечении нарушений, опосредованных св1 рецепторами
ATE437872T1 (de) Proteinkinaseinhibitoren
EA201001669A1 (ru) Замещенные пиримидин-5-карбоксамиды 281
DE602005016297D1 (de) Antithrombotische diamide
MY145408A (en) Dihydropyrazolopyrimidinone derivatives
TNSN07275A1 (fr) Derives de triazole substitues, servant d'antagonistes d'ocytocine
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
CY1107956T1 (el) Χρηση υποκατεστημενων 2-αμινοτετραλινιων για την προληπτικη αντιμετωπιση της νοσου του παρκινσον
MY151295A (en) Pyrimidyl indoline compound
MX2012000441A (es) Derivados de 1,2,4-tiazolidin-3-ona y uso en el tratamiento del cancer.
MX2010001020A (es) Derivados de pirimidina utiles para el tratamiento de condiciones inflamatorias o alergicas.
MA38315A1 (fr) Composés tétracycliques substitués par un hétérocycle et procédés pour les utiliser pour le traitement de maladies virales
TW200716547A (en) Piperidin-4-yl-amide derivatives
MX2010001566A (es) Derivado de aminopirazolamida.
CY1110950T1 (el) Ενωσεις ιμιδαζολιδινονυλ αμινοπυριμιδινης για τη θεραπευτικη αντιμετωπιση του καρκινου
DE602004008959D1 (de) Benzoäbüä1,4üdioxepinderivate
DE602007001463D1 (de) Pyrimidin-, chinazolin-, pteridin- und triazinderivate
MY158069A (en) Tricyclic compound and pharmaceutical use thereof
UA97483C2 (ru) Производное пиримидина в качестве ингибитора pi3k и его применение
MX2009006634A (es) Compuestos de imidazolidinonil aminopirimidina para el tratamiento de cancer.
DE602004031878D1 (de) Immunhemmende pyrazolon-verbindungen

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU